News | SPECT Imaging | July 25, 2016

UltraSPECT Xpress3.Cardiac Installed at Four RWJPE Locations

Wide-beam reconstruction technology increases patient safety and comfort, reduces nuclear radiation doses and shortens scan times

UltraSPECT, Xpress3.Cardiac, nuclear imaging, RWJPE, New Jersey, Robert Wood Johnson Physician Enterprise

July 25, 2016 — UltraSPECT Inc. announced recently that Robert Wood Johnson Physician Enterprise (RWJPE), a multi-specialty, community-based physician group in Central New Jersey, implemented UltraSPECT’s Xpress3.Cardiac solution at four of their sites. The sites include: Cardiology Associates of New Brunswick in New Brunswick, N.J.; Heart Specialists of Edison in Edison, N.J.; and New Brunswick Cardiology Group in their offices in Somerset and Monroe, N.J. 

The software will benefit patient safety by reducing the dosage of injected radiopharmaceuticals, while lowering the radiation exposure for patients and nuclear staff alike. In addition, the technology saves valuable time for patients and staff, as it can produce the same high-quality single photon emission computed tomography (SPECT) images in less time than is typically required during standard exams.

“The image quality and clarity are remarkably good with UltraSPECT, which is particularly impressive when you consider that our scan time has been reduced by half in 80-90 percent of the cases,” said Jose Torres, technology director, New Brunswick Cardiology Group, Somerset, N.J. “UltraSPECT also helped us eliminate the two-day study protocol for heavier patients, who used to have to come back the next day for a stress test because the shorter scan times allow us to do more in the same visit. Patients are also more comfortable during the scan because they have to lay still for a shorter period of time.”

Torres also notes that the radiation exposure numbers on staff’s monthly dosimetry reports have been steadily going down after the UltraSPECT implementation. This is due to both reduced scan time and reduced doses needed for imaging tests.

All four installations are part of RWJPE’s radiopharmaceutical supply agreement with Nuclear Diagnostic Products (NDP). NDP delivers high-quality diagnostic and therapeutic radiopharmaceuticals to its customers and offers UltraSPECT products to facilities looking for a cost-effective solution to achieve faster and safer imaging while enhancing their diagnostic capabilities.

For more information: www.ultraspect.com

Related Content

News | Nuclear Imaging

April 13, 2022 — The Society of Nuclear Medicine and Molecular Imaging (SNMMI) and the American Society of Nuclear ...

Home April 13, 2022
Home
Videos | Nuclear Imaging

American Society of Nuclear Cardiology (ASNC) President Dennis Calnon, M.D., MASNC, FASE, FSCCT, director of cardiac ...

Home February 01, 2022
Home
Feature | Nuclear Imaging | By Staff of the American Society of Nuclear Cardiology (ASNC)

A year after COVID-19 turned the world upside down, the American Society of Nuclear Cardiology (ASNC) asked members how ...

Home June 02, 2021
Home
News | Nuclear Imaging

April 1, 2021 – The ability to measure myocardial blood flow (MBF) as part of myocardial perfusion imaging (MPI) is one ...

Home April 01, 2021
Home
News | Nuclear Imaging

December 4, 2020 — Spectrum Dynamics Medical, Inc., has received Canadian Medical Device License from Health Canada for ...

Home December 04, 2020
Home
News | Nuclear Imaging

September 30, 2020 — Siemens Healthineers has introduced a new version of its c.cam dedicated cardiac nuclear medicine ...

Home October 07, 2020
Home
Feature | Nuclear Imaging | Dave Fornell, Editor

There were a few key takeaways from the American Society of Nuclear Cardiology (ASNC) 2019 annual meeting in September ...

Home November 22, 2019
Home
Videos | Nuclear Imaging

Rob Beanlands, M.D., FASNC, 2019 American Society of Nuclear Cardiology (ASNC) president, shares a couple trends he sees ...

Home November 07, 2019
Home
Videos | Nuclear Imaging

Robert C. Hendel, M.D., explains some of the new cardiac radiotracers in the pipeline that were discussed in sessions at ...

Home November 06, 2019
Home
Feature | Nuclear Imaging | Christopher A. Hanson M.D., and Jamieson M. Bourque M.D., MHS

Cardiac amyloidosis is a highly morbid and underdiagnosed infiltrative cardiomyopathy that is characterized by the ...

Home July 22, 2019
Home
Subscribe Now